Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study
Feagan BG, Sandborn WJ, D'Haens GR, Panes J, Kaser A, Ferrante M, Louis E, Dewit O, Seidler U, Kim KJ, Kligys K, Wallace K, Liao X, Lee WJ, Neurath M (2019)
Publication Type: Conference contribution
Publication year: 2019
Journal
Publisher: LIPPINCOTT WILLIAMS & WILKINS
City/Town: PHILADELPHIA
Pages Range: S482-S482
Conference Proceedings Title: AMERICAN JOURNAL OF GASTROENTEROLOGY
Event location: San Antonio, TX
DOI: 10.14309/01.ajg.0000592872.28570.f3
Authors with CRIS profile
Involved external institutions
AbbVie Deutschland GmbH & Co. KG
Germany (DE)
Western University
Canada (CA)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Academic Medical Centre / Academisch Medisch Centrum (AMC)
Netherlands (NL)
Asan Medical Center / 서울아산병원
Korea, Republic of (KR)
Cliniques universitaires Saint-Luc (CHU St-Luc)
Belgium (BE)
University of Cambridge
United Kingdom (GB)
Hospital Clínic de Barcelona
Spain (ES)
Centre Hospitalier Universitaire de Montpellier (CHU/CHRU MTP)
France (FR)
Centre Hospitalier Universitaire de Liège (CHU Liège)
Belgium (BE)
University of California, San Diego
United States (USA) (US)
Germany (DE)
Western University
Canada (CA)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Academic Medical Centre / Academisch Medisch Centrum (AMC)
Netherlands (NL)
Asan Medical Center / 서울아산병원
Korea, Republic of (KR)
Cliniques universitaires Saint-Luc (CHU St-Luc)
Belgium (BE)
University of Cambridge
United Kingdom (GB)
Hospital Clínic de Barcelona
Spain (ES)
Centre Hospitalier Universitaire de Montpellier (CHU/CHRU MTP)
France (FR)
Centre Hospitalier Universitaire de Liège (CHU Liège)
Belgium (BE)
University of California, San Diego
United States (USA) (US)
How to cite
APA:
Feagan, B.G., Sandborn, W.J., D'Haens, G.R., Panes, J., Kaser, A., Ferrante, M.,... Neurath, M. (2019). Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study. In AMERICAN JOURNAL OF GASTROENTEROLOGY (pp. S482-S482). San Antonio, TX, US: PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
MLA:
Feagan, Brian G., et al. "Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn's Disease: Analysis From a Phase 2 Study." Proceedings of the Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), San Antonio, TX PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2019. S482-S482.
BibTeX: Download